Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Corporativo FraguaB de CVCGSBF 87 Equity-to-Asset is 0.44 as of Dec. 2024, which is 4% below its 10-year median of 0.46. GuruFocus rates CGSBF with a GF Score™ of 87/100 and a GF Value™ of $43.12. Among 683 Healthcare Providers & Services companies, Corporativo FraguaB de CV ranks worse than 55.05% on this metric.
The historical rank and industry rank for Corporativo FraguaB de CV's Equity-to-Asset or its related term are showing as below:
CGSBF'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.44 Med: 0.46 Max: 0.55
Current: 0.44
During the past 13 years, the highest Equity to Asset Ratio of Corporativo FraguaB de CV was 0.55. The lowest was 0.44. And the median was 0.46.
CGSBF's Equity-to-Asset is ranked worse than 55.05% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 0.48
vs CGSBF: 0.44
Corporativo FraguaB de CV (OTCPK:CGSBF) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Corporativo FraguaB de CV Equity-to-Asset Related Terms
Corporativo FraguaB de CV Equity-to-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Corporativo FraguaB de CV Equity-to-Asset Competitor Comparison
For the Pharmaceutical Retailers subindustry, Corporativo FraguaB de CV's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Corporativo FraguaB de CV Equity-to-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Corporativo FraguaB de CV's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Corporativo FraguaB de CV's Equity-to-Asset falls into.
Corporativo FraguaB de CV Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Corporativo FraguaB de CV's Equity to Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Corporativo FraguaB de CV (CGSBF) has a Equity-to-Asset of 0.44 as of Dec. 2024. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Corporativo FraguaB de CV and its competitors. This is near median its historical median of 0.46. Over the past decade, Corporativo FraguaB de CV's Equity-to-Asset has ranged from 0.44 to 0.55. According to the industry distribution chart, Corporativo FraguaB de CV ranks #376 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 55.1%.
Is Corporativo FraguaB de CV's Equity-to-Asset too high?
Corporativo FraguaB de CV's current Equity-to-Asset of 0.44 is near median its 10-year median of 0.46. Over the past 10 years, this metric has ranged from a low of 0.44 to a high of 0.55. The Healthcare Providers & Services industry median Equity-to-Asset is 0.48. Corporativo FraguaB de CV's value of 0.44 is 8.3% below this industry median. Based on the distribution chart, Corporativo FraguaB de CV ranks #376 out of 683 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Corporativo FraguaB de CV has a GF Score™ of 87/100, reflecting its overall financial health beyond just this single metric.
How does Corporativo FraguaB de CV's Equity-to-Asset compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Corporativo FraguaB de CV ranks #376 out of 683 companies for Equity-to-Asset. This places Corporativo FraguaB de CV in the lower half of its industry. The industry median Equity-to-Asset is 0.48. Corporativo FraguaB de CV's value of 0.44 is 8.3% below this benchmark. Historically, Corporativo FraguaB de CV's own Equity-to-Asset has ranged from 0.44 to 0.55 over the past decade. While the company's 10-year median is 0.46 vs. the industry median of 0.48, Corporativo FraguaB de CV has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Healthcare Providers & Services company?
The median Equity-to-Asset among Healthcare Providers & Services companies is 0.48, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Corporativo FraguaB de CV's current Equity-to-Asset of 0.44 is 8.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Corporativo FraguaB de CV and its competitors. For the Healthcare Providers & Services industry, the median Equity-to-Asset is 0.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Corporativo FraguaB de CV's current Equity-to-Asset is 0.44, which is near median its own 10-year median of 0.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Corporativo FraguaB de CV stock overvalued right now?
Corporativo FraguaB de CV (CGSBF) has a current Equity-to-Asset of 0.44. The stock's GF Value™ is $43.12, compared to a current price of $29.66 — trading 31.2% below its estimated fair value. The current Equity-to-Asset is 0.44, which is near median its 10-year median of 0.46 and 8.3% below the Healthcare Providers & Services industry median of 0.48. Corporativo FraguaB de CV's overall GF Score™ is 87/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Corporativo FraguaB de CV (CGSBF), the current Equity-to-Asset is 0.44 as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Corporativo FraguaB de CV (CGSBF) Overvalued in 2026?
Based on GuruFocus' analysis, Corporativo FraguaB de CV stock appears to be undervalued.
The current stock price of $29.66 is trading 31.2% below its estimated GF Value™ of $43.12.
Key valuation signals for CGSBF:
Equity-to-Asset: 0.44 (near median its 10-year median of 0.46)
GF Value™: $43.12 vs. price of $29.66 (31.2% below fair value)
Industry Position: 8.3% below the Healthcare Providers & Services median (#376 of 683)
No single metric tells the full story. See the CGSBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Corporativo Fragua SAB de CV is engaged in the drug retail sector in Mexico. The company operates a network of pharmacies under the SuperFarmacia brand name, focusing on selling medicines, medical devices, and a variety of other products, including grocery items, exercise machines, perfumes, housewares, electronics, personal care products, toys, and photographic equipment.
87GF Score
Get the complete analysis for CGSBF
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CGSBF has been successfully added to your 
